Literature DB >> 28511279

Blast-associated traumatic brain injury in the military as a potential trigger for dementia and chronic traumatic encephalopathy.

James Hasoon1.   

Abstract

Traumatic brain injuries (TBIs) resulting from blast exposures have significantly affected US military personnel throughout the world, particularly in Iraq and Afghanistan. From 2000-2016, more than 350,000 military service members were diagnosed with a TBI. Since the majority of blast-related TBIs are classified as mild with no definitive findings on physical examination or diagnostic studies, it is difficult to accurately diagnose individuals inflicted with such injuries. There are likely far more mild TBIs that remain undiagnosed in the military. Traumatic brain injury is a serious public health concern since it can lead to long-term neuropsychiatric changes such as posttraumatic stress disorder and various forms of dementia. Blast-related TBI has also been linked with neuropsychiatric dysfunction that is commonly seen in athletes that have suffered chronic traumatic encephalopathy. Further research is needed to aid in prevention, diagnostic studies, and care of military service members and veterans who have suffered a TBI.

Entities:  

Mesh:

Year:  2017        PMID: 28511279

Source DB:  PubMed          Journal:  US Army Med Dep J        ISSN: 1524-0436


  2 in total

Review 1.  Psychological Stress-Induced Immune Response and Risk of Alzheimer's Disease in Veterans from Operation Enduring Freedom and Operation Iraqi Freedom.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Sudhanshu P Raikwar; Smita A Zaheer; Shankar S Iyer; Casey Burton; Donald James; Asgar Zaheer
Journal:  Clin Ther       Date:  2020-03-14       Impact factor: 3.393

2.  Impaired cognition in geriatric patients with relation to earlier life mood disorder and traumatic brain injury: a hypothesis.

Authors:  Edward H Tobe
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-24       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.